Analysis of how frontier AI and big tech acquisitions of early-stage biology platforms are reshaping exit dynamics for founders, investors, and pharma.
Key Takeaways
- Anthropic acquired Coefficient Bio for about $400 million
- Anthropic raised $30 billion at a $380 billion post-money valuation
- NVIDIA and Lilly announced a co-innovation AI lab to reinvent drug discovery